Clinical trial · Interventional
Effects of Infrared Laser Moxibustion on Cancer-related Fatigue in Breast Cancer Patients
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Cancer-related fatigue (CRF) is the most common and distressing symptom associated with tumor or cancer treatment that breast cancer survivors (BCS) experience.The investigators previously found the laser moxibustion was potentially efficacious for CRF; however, more rigorously designed study is needed to confirm its benefit. The primary aim of this study is to determine the efficacy of 10.6µm infrared laser moxibustion and its long-term effects on CRF. Secondary aims are to evaluate the effect of infrared laser moxibustion on co-existing symptoms such as among BCS experiencing CRF.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer-related Fatigue | Breast Neoplasm | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Infrared Laser Moxibustion | Device | — | UNRESOLVED |
| Sham Infrared Laser Moxibustion | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- type
- EXPERIMENTAL
- label
- Infrared Laser Moxibustion Therapy
- description
- Each patient will receive this treatment twice per week for six weeks (12 sessions total).
- interventionNames
- Device: Infrared Laser Moxibustion
- type
- SHAM_COMPARATOR
- label
- Sham Infrared Laser Moxibustion Therapy
- description
- The patients will receive treatment from sham laser moxibustion instrument.
- interventionNames
- Device: Sham Infrared Laser Moxibustion
- type
- NO_INTERVENTION
- label
- Waitlist Controls
- description
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: * Age between 18 years and 75 years * Breast cancer survivors with a diagnosis of stage I-IIIa * Cessation of cancer-related treatments (e.g. surgery, chemotherapy, radiotherapy) at least 12 weeks before the trial, with the exception of hormonal and trastuzumab therapy * Complaint of fatigue starting on or after their cancer diagnosis,Brief Fatigue Inventory score of ≥ 4 Exclusion Criteria: * Severe anemia (platelet count \<60,000/μL,hemoglobin \<8 g/dL, or leukocyte count\<3000/μL) * Abnormal findings in a thyroid function test (abnormal level of free thyroxine and thyroid stimulating hormone \<0.1 μIU/ml or TSH\> 5.1 μIU/ml) * Having received acupuncture for any indication in the previous 4 weeks or having received acupuncture test within the past 6 months. * Untreated major depressive disorder and suicidal ideations. * Pregnant or planning to become pregnant
References
Publications (1)
- DERIVEDMao H, Mao JJ, Chen J, Li Q, Chen X, Shen X, Zhao L, Wei J, Shen X. Effects of infrared laser moxibustion on cancer-related fatigue in breast cancer survivors: Study protocol for a randomized controlled trial. Medicine (Baltimore). 2019 Aug;98(34):e16882. doi: 10.1097/MD.0000000000016882. PMID 31441863